in

Oppong Nkrumah is a liar – Minority on why Information Minister-designate can’t be approved

Oppong Nkrumah is a liar – Minority on why Information Minister-designate can’t be approved

The Minority on the Appointments Committee has indicated that the Information Minister-designate Kojo Oppong Nkrumah was not the least candid especially on his private businesses when he took his turn at the vetting.

According to the Minority, the Ofoase Ayeribi MP has an 82% share in a company called Oval Market Finance. This finance company is believed to be involved in some suspicious third-party lending to West Brownstone which is also his.

The Minority on the Appointments Committee said the Minister is said to have denied outstanding obligations to Oval Microfinance despite the BoG’s examination report establishing the contrary.

Also, the Minority indicate that per their research and investigations, the Information Minister-designate has dealings with MX24 GH, a content creation, digital agency and media production house located in East Legon, which he said he didn’t have anything to do with during his vetting.

ALSO READ  You cannot say that in Court - Oppong Nkrumah boldly tells Tsatsu Tsikata

To add to this, the Minority indicate that Kojo Oppong Nkrumah peddled falsehood about the circumstances that led to the relocation of Manasseh Azure to South Africa after his life was threatened.

The Minority members on the Appointments Committee has rejected some nominees of Nana Addo Dankwa Akufo-Addo for the Ministerial position whiles some are still on pending and will be made to reappear before the Committee in a time to be decided.

Written by GhLinks Media

This is the official publishing account of https://www.ghlinks.com.gh/ for all general based post .

McBrown's Husband Trashes Divorce Rumours As He Gushes Over Actress' Latest Photos

McBrown’s Husband Trashes Divorce Rumours As He Gushes Over Actress’ Latest Photos

Kelvin Taylor

I cannot keep quite about this – Kelvin Taylor reacts after Akufo-Addo took first COVID-19 vaccine